A comprehensive evaluation of potentially significant drug-drug, drug-herb, and drug-food interactions among cancer patients receiving anticancer drugs

INTRODUCTION: During the cancer treatment path, cancer patients use numerous drugs, including anticancer, supportive, and other prescribed medications, along with herbs and certain products. This puts them at risk of significant drug interactions (DIs). This study describes DIs in cancer patients an...

Descripción completa

Detalles Bibliográficos
Autores principales: Koni, Amer A., Nazzal, Maisa A., Suwan, Bushra A., Sobuh, Samah S., Abuhazeem, Najiya T., Salman, Asil N., Salameh, Husam T., Amer, Riad, Zyoud, Sa’ed H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107751/
https://www.ncbi.nlm.nih.gov/pubmed/35568834
http://dx.doi.org/10.1186/s12885-022-09649-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107751/
https://www.ncbi.nlm.nih.gov/pubmed/35568834
http://dx.doi.org/10.1186/s12885-022-09649-3

Ejemplares similares